Loading the company…
Loading the company…
㈜포파코
English name as filed with DART, Korea’s corporate disclosure system · Correct the English name ›
Last updated 2026-10-11 · Korean page ›
Verification level — how far we have checked
L0 · Public records — NPS workforce · filed financials · patents — public data
A company based in Daegu, founded in 2013. Industry: Wholesale & Retail. Revenue for 2025 was ₩24.1bn. It has 83 employees enrolled in the National Pension Service (as of Aug 2026). It is externally audited; the latest audit opinion is “Unqualified”.
Loading…
Latest filing 2022-03-08 · latest registration 2022-11-17 · newest first
본 발명은 치아시드 추출물을 유효성분으로 포함하는 호흡기 질환 예방 또는 치료용 조성물에 관한 것으로, 본 발명의 조성물은 치아시드 추출물을 유효성분으로 포함함으로써 호흡기 기능 강화 및 호흡기 질환 개선 효과를 가지며, 치아시드 추출물을 사료(단미사료, 보조사료, 배합사료, 사료첨가제) 또는 영양제에 적용하여 호흡기 질환의 예방, 개선 또는 치료 효과를 나타낼 수 있다.
KIPO KIPRIS · checked 2026-10-15 · newest filings first · right: registration date (filing date if not yet registered) · 1 of 1 · titles and abstracts are in Korean as filed · click a row for details ▾
For now we hold public records only (National Pension Service · DART filings · patents · registers · press). When the company files material in our IR Room, it moves to L1. We do not score or rate companies — we only state how far we have checked.
| KRW bn | 2024 | 2025 |
|---|---|---|
| Revenue | 28.2 | 24.1 |
| Cost of sales | 18.4 | 14.9 |
| Gross profit (loss) | 9.7 | 9.2 |
| Selling, general and administrative expenses | 9.1 | 8.5 |
| Operating income (loss) | 0.6 | 0.7 |
| Non-operating income | 0.2 | 0.4 |
| Other gains | 0.1 | 0.3 |
| Finance income | 0.0 | 0.0 |
| Other | 0.0 | 0.0 |
| Non-operating expenses | 0.7 | 0.7 |
| Other losses | 0.0 | 0.0 |
| Finance costs | 0.6 | 0.6 |
| Other | 0.0 | 0.1 |
| Profit (loss) before tax | 0.1 | 0.4 |
| Net income (loss) | 0.1 | 0.4 |
Revenue ₩24.1bn, down 14.5% YoY.
Operating margin 2.9% (prior 2.2%).
Net income ₩0.4bn.
Need more than is shown here? Ask for more information — full review report · valuation · executive teaser · IM · competitor analysis · due diligence. Tell us what you need and we will reply by email with scope, cost and timing.
Is this your company?
If anything here is wrong, tell us — we check it against the original and correct it. You do not need to join. If you would like your financials verified and this page completed, that is a separate process.
Headlines and links to public articles only · not checked by us (original ↗) · articles are in Korean — English headlines are our translation; where none is shown, “Read in English ›” opens a machine translation · “Broker view” is a forecast, not reported results · checked 2026-11-06